Know Labs, Inc. , a leading developer of non-invasive diagnostics technology released this morning an overview of its Form 10-K annual report for its fiscal year ending September 30, 2024, and ...

This week Bobbi Conner talks with MUSC's Dr. Aundrea Loftley about using a continuous glucose monitor for diabetes management ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its A ...

In recent years, technological advancements in healthcare have revolutionised the management of chronic conditions like ...

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the fourth quarter and fiscal ...

New AI-powered tool uses high-speed video to detect blood pressure and diabetes markers without invasive procedures or ...

“An average is not a very good way of measuring what is your control,” he said. “When you have those big excursions of highs ...

particularly in the shift toward less invasive procedures. Here, we explore some of the most promising advancements shaping ...

A novel system combining high-speed video and AI algorithms could revolutionize health screenings for high blood pressure and ...